245 related articles for article (PubMed ID: 10502735)
1. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
Salvesen HB; Akslen LA
Int J Cancer; 1999 Oct; 84(5):538-43. PubMed ID: 10502735
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
[TBL] [Abstract][Full Text] [Related]
3. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis of endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels.
Lee CN; Cheng WF; Chen CA; Chu JS; Hsieh CY; Hsieh FJ
Obstet Gynecol; 2000 Oct; 96(4):615-21. PubMed ID: 11004369
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
7. Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas.
Oh CK; Kwon YW; Kim YS; Jang HS; Kwon KS
J Dermatol; 2003 Apr; 30(4):306-13. PubMed ID: 12707467
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung.
Minami K; Saito Y; Imamura H; Okamura A
Lung Cancer; 2002 Oct; 38(1):51-7. PubMed ID: 12367793
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1, vascular endothelial growth factor expression and microvessel density in renal cell carcinoma and their relationship with multifocality.
Baltaci S; Orhan D; Göğüş C; Filiz E; Tulunay O; Göğüş O
Eur Urol; 2003 Jul; 44(1):76-81; discussion 81. PubMed ID: 12814678
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
[TBL] [Abstract][Full Text] [Related]
15. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia.
Kwak C; Jin RJ; Lee C; Park MS; Lee SE
BJU Int; 2002 Feb; 89(3):303-9. PubMed ID: 11856116
[TBL] [Abstract][Full Text] [Related]
17. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer.
Leek RD; Hunt NC; Landers RJ; Lewis CE; Royds JA; Harris AL
J Pathol; 2000 Mar; 190(4):430-6. PubMed ID: 10699991
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
19. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N
Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis and endometrial cancer.
Sivridis E
Anticancer Res; 2001; 21(6B):4383-8. PubMed ID: 11908694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
